Pharmacotherapeutics

A patient being treated for erectile dysfunction is prescribed sildenafil 50 mg PRN. Which assessment finding would be most concerning to the provider?

A prescriber is providing education to a patient who is beginning therapy with testosterone gel. Which statement made by the patient demonstrates a need for further teaching?

A prescriber is teaching a male adult patient about the use of testosterone gel. Which statement by the patient indicates an understanding of the teaching?

An adult patient anemia following cancer chemotherapy will now begin treatment with testosterone. Which statement by the patient indicates understanding of the provider's teaching?

A provider assesses an adolescent male patient who has been receiving androgen therapy for hypogonadism via a transdermal patch. The patient's last clinic visit was 4 weeks earlier. Which part of the interval history is of greatest concern to the provider?

An adult male patient will begin androgen therapy for testicular failure. Which statement by the patient indicates understanding of the treatment regimen as provided by the prescriber?

A 14-year-old male patient is admitted to the hospital following a football injury. The patient is muscular, has a deep voice, and full beard. Which tests will the provider order in response to these assessment findings? (Select all that apply.)

After being educated about administration of papaverine plus phentolamine for erectile dysfunction, which statement made by the patient indicates a need for further teaching by the prescriber?

A patient prescribed dutasteride 2 weeks ago reports continued urinary hesitancy. Which action by a provider is most appropriate?

A 14-year-old male patient diagnosed with hypogonadism will begin testosterone patch therapy. What information will the prescriber include when teaching the family about this therapy?

A 14-year-old male patient who has not yet begun puberty reports being bullied at school. The boy's father reports that he and his father also experienced teasing as adolescents because they did not begin puberty until around age 16 years. What will the provider tell the patient and his father when they ask what can be done?

A patient receiving intracavernousal alprostadil discusses switching to the transurethral administration route. Which information does the provider include as a benefit of changing administration routes?

A patient receiving doxazosin presents for a routine evaluation. Which assessment finding related to the medication therapy would be most concerning to the provider?

Which finding indicates that terazosin has been effective for a patient with benign prostatic hypertrophy (BPH)?